Pharmaceutical compositions and methods for restoring β-cell mass and function
AssigneeDiakine Therapeutics, Inc.
InventorJerry L. Nadler
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions and methods for using are provided for restoring β-cell mass and function in a mammal in need thereof. The pharmaceutical compositions have a biological response modifier and a β-cell growth factor in admixture with a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claims1
A method for treating Type 1 diabetes, autoimmune diabetes, or insulin dependent diabetes mellitus (IDDM) comprising administering to a mammal in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a biological response modifier and a β-cell growth or differentiating factor in admixture with a pharmaceutically acceptable carrier, adjuvant or vehicle;
- wherein the biological response modifier is lisofylline and the β-cell growth or differentiating factor is exendin-4 or exenatide.
Dependencies are inferred from the claim text.